Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00287404 · ClinicalTrials.gov registry record
Measuring Cholesterol in the Fasting and Postmeal State in Patients With Type 2 Diabetes
A clinical trial, sponsored by University of North Carolina.
- Completed
- Registry status
- 30
- Enrollment target
NCT00287404: Completed study, sponsored by University of North Carolina.
NCT00287404 is a clinical trial that has completed, run by University of North Carolina. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00287404 has completed, sponsored by University of North Carolina.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Many patients with type 2 diabetes have difficulty attaining cholesterol goals, partly due to the recommendations for fasting measurements that may not be practical in the typical clinical setting. Focus toward therapy is shifting toward non-fasting assessments but little is known about the usefulness of this approach in diabetes, where postmeal cholesterol levels are more abnormal. This is an observational study examining fasting and postmeal lipids (cholesterol) in patients with type 2 diabetes using standard means and NMR.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-10 |
| Est. Completion | 2006-09 |
What the finished NCT00287404 record still lists
NCT00287404 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00287404 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00287404 about?
NCT00287404 is a clinical study titled "Measuring Cholesterol in the Fasting and Postmeal State in Patients With Type 2 Diabetes". Many patients with type 2 diabetes have difficulty attaining cholesterol goals, partly due to the recommendations for fasting measurements that may not be practical in the typical clinical setting. Focus toward therapy is shifting toward non-fasting assessments but little is known about the usefulne...
What is the current status of trial NCT00287404?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2005-10. Estimated completion is 2006-09.
Who is sponsoring clinical trial NCT00287404?
This trial is sponsored by University of North Carolina, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia